Danimer Scientific, Inc.
NYSE:DNMR
0.3847 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 59.17 | 62.792 | 286.487 | 377.581 | 6.261 | 6.317 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 59.17 | 62.792 | 286.487 | 377.581 | 6.261 | 6.317 |
| Net Receivables
| 18.884 | 24.311 | 24.561 | 8.071 | 5.523 | 6.962 |
| Inventory
| 25.27 | 32.743 | 24.573 | 13.642 | 7.038 | 4.045 |
| Other Current Assets
| 4.714 | 5.225 | 4.737 | 3.089 | 0.417 | 0.713 |
| Total Current Assets
| 108.038 | 125.071 | 340.358 | 402.383 | 19.239 | 18.037 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 464.313 | 472.977 | 335.421 | 126.182 | 92.407 | 54.66 |
| Goodwill
| 0 | 0 | 62.649 | 0 | 0 | 0 |
| Intangible Assets
| 77.79 | 80.941 | 84.659 | 1.801 | 2.052 | 2.333 |
| Goodwill and Intangible Assets
| 77.79 | 80.941 | 147.308 | 1.801 | 2.052 | 2.333 |
| Long Term Investments
| 45.78 | 33.055 | -1.014 | 15.724 | 30.759 | 0 |
| Tax Assets
| 32.154 | 0.2 | 1.014 | -15.724 | -30.759 | 0 |
| Other Non-Current Assets
| 2.21 | 0.026 | 15.51 | 15.835 | 30.875 | 39.22 |
| Total Non-Current Assets
| 622.247 | 587.199 | 498.239 | 143.818 | 125.334 | 96.213 |
| Total Assets
| 730.285 | 712.27 | 838.597 | 546.201 | 144.573 | 114.25 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 5.292 | 14.977 | 20.79 | 10.61 | 8.12 | 1.137 |
| Short Term Debt
| 4.705 | 5.309 | 3.694 | 28.201 | 11.86 | 2.037 |
| Tax Payables
| 0.552 | 0.669 | 0.5 | 0 | 0 | 0 |
| Deferred Revenue
| 1 | 0.2 | 0.214 | 2.455 | 4.58 | 0 |
| Other Current Liabilities
| 4.726 | 4.801 | 18.777 | 9.22 | 9.724 | 9.464 |
| Total Current Liabilities
| 15.723 | 25.287 | 43.475 | 50.486 | 34.284 | 12.638 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 381.436 | 308.512 | 283.627 | 55.561 | 91.213 | 74.424 |
| Deferred Revenue Non-Current
| 21.927 | 0 | 9.578 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 32.154 | 0.2 | 1.014 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.025 | 0.659 | 0.638 | 1.25 | 2.5 | 0 |
| Total Non-Current Liabilities
| 436.542 | 309.371 | 294.857 | 56.811 | 93.713 | 74.424 |
| Total Liabilities
| 452.265 | 334.658 | 338.332 | 107.297 | 127.997 | 87.062 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.01 | 0.01 | 0.01 | 0.008 | 0.003 | 0.003 |
| Retained Earnings
| -454.121 | -298.648 | -118.89 | -62.503 | -49.93 | -29.566 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 732.131 | 676.25 | 619.145 | 501.399 | 66.503 | 56.751 |
| Total Shareholders Equity
| 278.02 | 377.612 | 500.265 | 438.904 | 16.576 | 27.188 |
| Total Equity
| 278.02 | 377.612 | 500.265 | 438.904 | 16.576 | 27.188 |
| Total Liabilities & Shareholders Equity
| 730.285 | 712.27 | 838.597 | 546.201 | 144.573 | 114.25 |